Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Kaufman JL, Mina R, Shah JJ, Laubach JP, Nooka AK, Lewis C, Gleason C, Sharp C, Harvey RD, Heffner LT, Richardson P, Lonial S, Orlowski RZ.
Kaufman JL, et al. Among authors: gleason c.
Clin Lymphoma Myeloma Leuk. 2020 Dec;20(12):797-803. doi: 10.1016/j.clml.2020.07.013. Epub 2020 Jul 25.
Clin Lymphoma Myeloma Leuk. 2020.
PMID: 32819881
Free article.
Clinical Trial.